Exponent, Inc. (NASDAQ:EXPO) has received an average recommendation of “Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $45.00.
A number of research analysts recently commented on the stock. BidaskClub lowered shares of Exponent from a “strong-buy” rating to a “buy” rating in a research note on Friday. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $55.00 price objective on the stock in a research note on Monday, October 22nd. Finally, Berenberg Bank assumed coverage on shares of Exponent in a research note on Wednesday, September 12th. They set a “buy” rating on the stock.
Shares of EXPO traded down $0.02 during mid-day trading on Monday, reaching $50.32. 198,614 shares of the company’s stock traded hands, compared to its average volume of 253,708. The stock has a market cap of $2.62 billion, a PE ratio of 47.03 and a beta of 0.61. Exponent has a 12 month low of $34.90 and a 12 month high of $54.58.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Friday, December 7th will be paid a dividend of $0.13 per share. The ex-dividend date of this dividend is Thursday, December 6th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.03%. Exponent’s dividend payout ratio is presently 48.60%.
In related news, VP Harri Kytomaa sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $51.50, for a total transaction of $154,500.00. Following the transaction, the vice president now owns 6,090 shares in the company, valued at $313,635. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 2.80% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. grew its position in Exponent by 121.0% in the second quarter. BlackRock Inc. now owns 7,238,515 shares of the business services provider’s stock worth $349,620,000 after buying an additional 3,963,618 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Exponent by 88.3% in the second quarter. Dimensional Fund Advisors LP now owns 1,736,818 shares of the business services provider’s stock worth $83,890,000 after buying an additional 814,572 shares during the last quarter. Janus Henderson Group PLC grew its position in Exponent by 109.9% in the second quarter. Janus Henderson Group PLC now owns 1,062,498 shares of the business services provider’s stock worth $51,319,000 after buying an additional 556,278 shares during the last quarter. Renaissance Technologies LLC grew its position in Exponent by 88.4% in the second quarter. Renaissance Technologies LLC now owns 1,099,651 shares of the business services provider’s stock worth $53,113,000 after buying an additional 515,851 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in Exponent by 91.5% in the second quarter. PNC Financial Services Group Inc. now owns 1,022,703 shares of the business services provider’s stock worth $49,397,000 after buying an additional 488,689 shares during the last quarter. Institutional investors and hedge funds own 89.04% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Read More: Google Finance
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.